![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1175.jpg)
•
Retrospective review of 42
patients, 4 institutions
•
Overall survival (OS) and local
control (LC)
•
Stratified by maxBED
10
using
max point dose in PTV
•
Median OS was 27.8 months
vs. 14.8 months!
Clinical results Viewray: Pancreas SBRT
Rudra et al., ASTRO 2017